USAID Backs Development of New Malaria Vaccine

A child gets tested for malaria in Kenya. Photo by: U.S. Army Africa / CC BY

The U.S. Agency for International Development and the International Disease Research Institute, a U.S.-based nonprofit organization, have agreed to jointly support the development of a new vaccine to fight malaria.

Under a memorandum of agreement, the two agencies will collaborate with the Walter Reed Army Institute of Research for the clinical trial of a malaria vaccine candidate that combines an antigen developed by WRAIR with IDRI’s potent immunological agent.

Read more on U.S. aid reform online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

About the author

  • Ivy Mungcal

    As former senior staff writer, Ivy Mungcal contributed to several Devex publications. Her focus is on breaking news, and in particular on global aid reform and trends in the United States, Europe, the Caribbean, and the Americas. Before joining Devex in 2009, Ivy produced specialized content for U.S. and U.K.-based business websites.